Cargando…
Decreased oxidative stress and altered urinary oxylipidome by intravenous omega-3 fatty acid emulsion in a randomized controlled trial of older subjects hospitalized for COVID-19
Proinflammatory bioactive lipid mediators and oxidative stress are increased in coronavirus disease 2019 (COVID-19). The randomized controlled single-blind trial COVID-Omega-F showed that intravenous omega-3 polyunsaturated fatty acids (n-3 PUFA) shifted the plasma lipid signature of COVID-19 toward...
Autores principales: | Pawelzik, Sven-Christian, Arnardottir, Hildur, Sarajlic, Philip, Mahdi, Ali, Vigor, Claire, Zurita, Javier, Zhou, Bingqing, Kolmert, Johan, Galano, Jean-Marie, Religa, Dorota, Durand, Thierry, Wheelock, Craig E., Bäck, Magnus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733960/ https://www.ncbi.nlm.nih.gov/pubmed/36509313 http://dx.doi.org/10.1016/j.freeradbiomed.2022.12.006 |
Ejemplares similares
-
Immunomodulation by intravenous omega‐3 fatty acid treatment in older subjects hospitalized for COVID‐19: A single‐blind randomized controlled trial
por: Arnardottir, Hildur, et al.
Publicado: (2022) -
Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the COVID-Omega-F Trial
por: Arnardottir, Hildur, et al.
Publicado: (2021) -
The resolution of inflammation through omega-3 fatty acids in atherosclerosis, intimal hyperplasia, and vascular calcification
por: Carracedo, Miguel, et al.
Publicado: (2019) -
Omega-3 Polyunsaturated Fatty Acids Decrease Aortic Valve Disease Through the Resolvin E1 and ChemR23 Axis
por: Artiach, Gonzalo, et al.
Publicado: (2020) -
The Plasma Oxylipidome Links Smoking Status to Peripheral Artery Disease
por: Caligiuri, Stephanie P. B., et al.
Publicado: (2022)